ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiology"

  • Abstract Number: 1081 • ACR Convergence 2024

    Evaluation of Methods for Ascertainment and Categorization of Race and Ethnicity for Clinical Research: An Umbrella Review

    Teresa Semalulu1, Melanie Anderson2, Shahad Al-Matar1, SADEEM ALFRAIH1, Azza Eissa3, Emma Neary4, Fadi Kharouf5, Abimbola Saka3, Zayd Schafer6, Zahi Touma1 and Sindhu Johnson7, 1University of Toronto, Toronto, ON, Canada, 2The Institute for Education Research, Library and Information Services, University Health Network, Toronto, ON, Canada, 3University of Toronto, Toronto, 4McGill University, Montreal, QC, 5University Health Network and University of Toronto, Toronto, ON, Canada, Toronto, ON, Canada, 6American University of Antigua, Saint John's, 7Division of Rheumatology, Department of Medicine, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western and Mount Sinai Hospitals; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Race and ethnicity are increasingly evaluated in rheumatology research due to their influence on health outcomes, yet there remains heterogeneity in their interpretation and…
  • Abstract Number: 1336 • ACR Convergence 2024

    Risk of Malignancy Under the Treatments with Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis: An Analysis Using Japanese Health Insurance Database

    Ryoko Sakai1, Eiichi Tanaka2, Eisuke Inoue3 and Masayoshi Harigai4, 1Meiji Pharmaceutical University, Tokyo, Japan, 2Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan, 3Showa University, Tokyo, Japan, 4Tokyo Women's Medical University, Tokyo, Japan

    Background/Purpose: Janus kinase inhibitors (JAKIs) have shown positive therapeutic impacts on treatments for rheumatoid arthritis (RA), whereas, there are concerns about the risk of malignancy…
  • Abstract Number: 1720 • ACR Convergence 2024

    Herpes Zoster Risk Following Initiation of Immunosuppressive Therapy Among Adults with Rheumatic Disease

    Justin Gatwood1, Yong Zhu2, Andrea Steffens2, Stephanie Gallagher2, Mary DuCharme2 and Nikita Stempniewicz1, 1GSK, Philadelphia, PA, 2Optum Life Sciences, Eden Prairie, MN

    Background/Purpose: Previous studies have demonstrated that the risk of herpes zoster (HZ) among adults with rheumatic disease, such as rheumatoid arthritis (RA), psoriatic arthritis (PsA),…
  • Abstract Number: 1891 • ACR Convergence 2024

    Association of Physical Activity Levels on Chronic Opioid Use in Radiographic Axial Spondylitis Patients

    Rutvin Kyada1, Jean Liew2, Maureen Dubreuil3, Matthew Brown4, Mariko Ishimori5, John Reveille6, Michael Ward7, Michael Weisman8 and Lianne S Gensler9, 1Boston University, Boston, MA, 2Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 3Section of Rheumatology, Boston University School of Medicine, Boston, MA, 4King's College London, London, United Kingdom, 5Cedars-Sinai Health System, Los Angeles, CA, 6UTHealth Houston Division of Rheumatology, Houston, 7NIH, Bethesda, MD, 8Stanford University, Los Angeles, CA, 9Department of Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA

    Background/Purpose: Pain remains a common symptom of axial spondyloarthritis (axSpA) despite availability of effective therapies. Physical activity may benefit pain and is guideline recommended but…
  • Abstract Number: 2031 • ACR Convergence 2024

    A Contemporary Assessment of the Burden of Malignancy in IgG4-Related Disease

    Grace McMahon1, Isha Jha1, Guy Katz1, Cory Perugino1, Ana Fernandes1, John Stone2 and Zachary Wallace3, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital , Harvard Medical School, Concord, MA, 3Massachusetts General Hospital, Newton, MA

    Background/Purpose: IgG4-related disease (IgG4-RD) is a fibro-inflammatory disorder that can affect nearly any organ. Because of the often tumefactive nature of IgG4-RD and its typical…
  • Abstract Number: 2421 • ACR Convergence 2024

    Trends in Glucocorticoid Use in Systemic Lupus Erythematosus in a Population-Based Inception Cohort from 1976 to 2018: The Lupus Midwest Network

    Mariana Gonzalez-Trevino1, Jaime Flores Gouyonnet1, Qiping Xu2, Cassondra Hulshizer3, Jose Meade-Aguilar4, Erika Navarro-Mendoza1, Mario Bautista-Vargas5, Gabriel Figueroa-Parra6, Alain Sanchez-Rodriguez7, Maria Cuellar-Gutierrez1, Andrew C. Hanson8, Cynthia Crowson1 and Ali Duarte-Garcia1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic Health System - Mankato, Mankato, MN, 3Mayo Clinic, Utica, MN, 4Boston University/Boston Medical Center, Boston, MA, 5Mayo Clinic, Rochester, Minnesota, USA., Rochester, MN, 6Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 7Mayo Clinic College of Medicine and Science, Rochester, MN, 8Mayo Clinic, Rochester

    Background/Purpose: We examined the patterns of glucocorticoid (GC) use and the temporal trends of GC initiation, discontinuation, and reduction over four decades in a population-based…
  • Abstract Number: 2666 • ACR Convergence 2024

    The Risk for Development of Myositis Is Not Increased After COVID-19 Vaccination Among U.S. Veterans

    Caleb Hernandez1, Naomi Schlesinger2, Jorge Rojas3, Jessica A Walsh4, Tawnie Braaten2, Gary Kunkel5, Makoto Jones2, Sauer brian6, Julio Facelli1, grant Cannon7 and Dorota Lebiedz-Odrobina8, 1University of Utah, Salt Lake City, 2University of Utah, Salt Lake City, UT, 3Seattle VA, Mexico, Mexico, 4Division of Rheumatology, Salt Lake City Veterans Affairs Health and University of Utah Health, Salt Lake City, UT, 5University of Utah and George E Wahlen VAMC, Salt Lake City, UT, 6Salt Lake City VA/University of Utah, Salt Lake City, UT, 7University of Utah and Salt Lake City VA, Salt Lake City, UT, 8University of Utah, Cottonwood Heights, UT

    Background/Purpose: Several case reports and case series of idiopathic inflammatory myositis (IIM) following COVID-19 vaccination have been reported. This study evaluated the association of prior…
  • Abstract Number: 0160 • ACR Convergence 2024

    Supplement Use in a Diverse Cohort of Individuals with SLE

    Russell Ellyson1, Jinoos Yazdany2, S. Sam Lim3, Brad Pearce3 and Laura Plantinga4, 1Alameda Health System, Highland Hospital, Oakland, CA, 2UCSF, San Francisco, CA, 3Emory University, Atlanta, GA, 4University of California, San Francisco, San Francisco, CA

    Background/Purpose: Supplement use among individuals with SLE is not well-characterized, despite potential effects of some supplements on SLE activity or on treatments for SLE or…
  • Abstract Number: 0412 • ACR Convergence 2024

    Impact of Approval of Biologic DMARDs on JIA Outcomes in a Single Center

    Anna Sutton1, Erin Balay-Dustrude1, Beth A Mueller1 and Susan Shenoi2, 1University of Washington, Seattle, WA, 2Seattle Children's Hospital and Research Center, Mercer Island, WA, WA

    Background/Purpose: In clinical trials, biologic disease-modifying antirheumatic drugs (bDMARDs) for juvenile idiopathic arthritis (JIA) have demonstrated good efficacy. However, less is known about the impact…
  • Abstract Number: 0687 • ACR Convergence 2024

    Patterns of Disease Progression in Early Systemic Sclerosis Patients with Interstitial Lung Disease

    Lorenzo Beretta1, Alessandro Santaniello2, Silvia Bosello3, Enrico De Lorenzis4, Gerlando Natalello5, Nicoletta Del Papa6, Silvia Cavalli7, Devis Benfaremo8, Giacomo De Luca9, Corrado Campochiaro10, Lorenzo Cavagna11, Veronica Codullo12, Francesco Bonomi13, gaia Montanelli14, Adriana Severino15, Monica Caronni2, Barbara Vigone2, Silvia Bellando-Randone16, Carlomaurizio Montecucco17, Marco Matucci-Cerinic18, Lorenzo Dagna19, Gianluca Moroncini8, Roberto Caporali20 and Chiara Bellocchi21, 1Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di MIlano, Milan, Milan, Italy, 2Fondazione IRCCS Ca' Granda Ospedale Policlinico di Milano, MILANO, Italy, 3FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI- IRCCS, Rome, Rome, Italy, 4Catholic University of the Sacred Heart, Roma, Rome, Italy, 5Division of Rheumatology - Catholic University of the Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Rome, Italy, 6ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO, Milano, Milan, Italy, 7University of Milan, Milan, Milan, Italy, 8Marche Polytechnic University, Ancona, Italy, 9Vita-Salute San Raffaele University & IRCCS San Raffaele Hospital, Milan, Milan, Italy, 10IRCCS San Raffaele Hospital. Vita-Salute San Raffaele University, Milan, Milan, Italy, 11University of Pavia and Fondazione IRCCS Policlinico San Matteo Hospital of Pavia, Pavia, Pavia, Italy, 12Division of Rheumatology - Policlinico San Matteo, Pavia, Italy, Pavia, Lombardia, Italy, 13Azienda Ospedaliera Universitaria Careggi, Florence, Florence, Italy, 14Fondazione IRCCS Ca' Granda Ospedale Policlinico di Milano, Milan, Italy, 15Fondazione IRCCS Ca' Granda Ospedale Policlinico di Milano, Milan, Milan, Italy, 16University of Florence, Florence, Florence, Italy, 17IRCCS policlinico S. Matteo foundation, University of Pavia, Pavia, Italy, 18University San Raffaele Milano, Milano, Milan, Italy, 19Ospedale San Raffaele, Milano, Italy, 20Department of Clinical Sciences and Community Health, University of Milan, and Department of Rheumatology and Medical Sciences, ASST Gaetano Pini-CTO, Milan, Italy, 21Università degli Studi di Milano, IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy

    Background/Purpose: Understanding the trajectory of disease progression in SSc-ILD is crucial for effective patient management and prognostication. Trajectory modeling offers a novel approach to deciphering…
  • Abstract Number: 0990 • ACR Convergence 2024

    Predictors of Adverse Events and Complications in Cirrhotic Patients with Rheumatoid Arthritis: A Nationwide Analysis

    Nidaa Rasheed1, Humzah Iqbal2 and Candice Reyes3, 1UCSF Fresno, Fresno, CA, 2UCSF FRESNO, FRESNO, 3VACCHCS, Fresno, CA

    Background/Purpose: Cirrhosis is associated with a host of complications such as coagulopathy, renal impairment, esophageal varices, peritonitis, and increased mortality. Rheumatoid arthritis (RA) is a…
  • Abstract Number: 1093 • ACR Convergence 2024

    Risk of Dementia in Patients with Gout: Potential Impact of Survival Bias

    Joshua Baker1, Lindsay Helget2, chung-Chou Chang3, Bryant England2, Brian Coburn1, Harlan Sayles2, Punyasha Roul4 and Ted Mikuls2, 1University of Pennsylvania, Philadelphia, PA, 2University of Nebraska Medical Center, Omaha, NE, 3University of Pittsburgh, Pittsburgh, PA, 4UNMC, Omaha, NE

    Background/Purpose: Prior studies reported a lower risk of dementia among patients with gout suggesting that hyperuricemia might play a neuroprotective role. However, risk estimates for…
  • Abstract Number: 1343 • ACR Convergence 2024

    Heightened Gout Risk in Patients with Rheumatoid Arthritis: A National Cohort Study

    Seonyoung Kang1, Yeonghee Eun2, Kyungdo Han3, Jinhyung Jung4, Seulkee Lee5, Hoon-Suk Cha6, Hyungjin Kim7, Jaejoon Lee5 and Dong Wook Shin8, 1Samsung Medical Center, Gangnam-gu, Seoul, South Korea, 2Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Jongno-gu, Seoul, Republic of Korea, 3Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea, 4Department of Medical Statistics, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea, 5Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, 6Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, 7Department of Medical Humanities, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, 8Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul

    Background/Purpose: Although gout is a prevalent disease, the coexistence of rheumatoid arthritis (RA) and gout has been considered unusual. Only several case reports describing the…
  • Abstract Number: 1748 • ACR Convergence 2024

    Fracture Incidence Rates in Persons with Rheumatoid Arthritis by Disease Activity Level

    Rachel Elam1, Emma Kersey2, Jing Li3, Gabriela Schmajuk4 and Laura Carbone5, 1Augusta University, Evans, GA, 2University of California San Francisco, San Francisco, CA, 3University of California, San Francisco, San Francisco, CA, 4UCSF / SFVA, San Francisco, CA, 5Augusta University, Augusta, GA

    Background/Purpose: Fracture incidence rates (IRs) are higher in men and women with rheumatoid arthritis (RA) than those without RA, especially for those with higher RA…
  • Abstract Number: 1892 • ACR Convergence 2024

    Early Tumor Necrosis Factor Inhibitor Initiation and Chronic Opioid Use in Individuals with Axial Spondyloarthritis

    Eva Petrow1, Jose Meade Aguilar2, Christine Peloquin3, S. Reza Jafarzadeh3, Tuhina Neogi3, Maureen Dubreuil4 and Jean Liew3, 1Boston University/Boston Medical Center, Boston, MA, 2Boston Medical Center, Boston, MA, 3Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 4Section of Rheumatology, Boston University School of Medicine, Boston, MA

    Background/Purpose: Patients with axial spondyloarthritis (axSpA) bear a substantial burden of chronic opioid use despite the availability of effective treatments like tumor necrosis factor inhibitors…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 46
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology